The specter of generic challenges has consistently loomed around copyright’s iconic drug, Viagra, triggering questions about the future of connected medicinal holdings. While first years saw significant returns, the exclusivity expiration has created the way for discounted copies, likely reducing profitability and posing a real danger for invest… Read More